SMRI vs. PRXV
SMRI (Bushido Capital US Equity ETF) and PRXV (Praxis Impact Large Cap Value ETF) are both Large Cap Value Equities funds. Both are actively managed. At a 0.20 correlation, their price movements are largely independent. SMRI charges 0.71%/yr vs 0.36%/yr for PRXV.
Performance
SMRI vs. PRXV - Performance Comparison
Loading charts...
Returns By Period
SMRI
- 1D
- -0.15%
- 1M
- 11.41%
- YTD
- 18.58%
- 6M
- 18.82%
- 1Y
- 35.67%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
PRXV
- 1D
- -0.03%
- 1M
- 4.27%
- YTD
- —
- 6M
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
SMRI vs. PRXV - Yearly Performance Comparison
| 2026 (YTD) | |
|---|---|
SMRI Bushido Capital US Equity ETF | 13.54% |
PRXV Praxis Impact Large Cap Value ETF | 4.51% |
Correlation
The correlation between SMRI and PRXV is 0.20, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Apr 21, 2026 | 0.20 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SMRI vs. PRXV — Risk / Return Rank
SMRI
PRXV
SMRI vs. PRXV - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Bushido Capital US Equity ETF (SMRI) and Praxis Impact Large Cap Value ETF (PRXV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| SMRI | PRXV | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | 1.44 | — | — |
| Calmar ratioReturn relative to maximum drawdown | 5.27 | — | — |
| Martin ratioReturn relative to average drawdown | 16.62 | — | — |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| SMRI | PRXV | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.46 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 1.44 | 4.54 | -3.10 |
Drawdowns
SMRI vs. PRXV - Drawdown Comparison
The maximum SMRI drawdown since its inception was -18.45%, which is greater than PRXV's maximum drawdown of -1.18%. Use the drawdown chart below to compare losses from any high point for SMRI and PRXV.
Loading charts...
Drawdown Indicators
| SMRI | PRXV | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -18.45% | -1.18% | -17.27% |
Max Drawdown (1Y)Largest decline over 1 year | -6.80% | — | — |
Current DrawdownCurrent decline from peak | -1.17% | -0.03% | -1.14% |
Average DrawdownAverage peak-to-trough decline | -2.71% | -0.32% | -2.39% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.15% | — | — |
Volatility
SMRI vs. PRXV - Volatility Comparison
Loading charts...
Volatility by Period
| SMRI | PRXV | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.42% | — | — |
Volatility (6M)Calculated over the trailing 6-month period | 10.94% | — | — |
Volatility (1Y)Calculated over the trailing 1-year period | 14.63% | 9.66% | +4.97% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 15.84% | 9.66% | +6.18% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 15.84% | 9.66% | +6.18% |
SMRI vs. PRXV - Expense Ratio Comparison
SMRI has a 0.71% expense ratio, which is higher than PRXV's 0.36% expense ratio.
Dividends
SMRI vs. PRXV - Dividend Comparison
SMRI's dividend yield for the trailing twelve months is around 0.95%, while PRXV has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 |
|---|---|---|---|---|
PRXV Praxis Impact Large Cap Value ETF | 0.00% | 0.00% | 0.00% | 0.00% |
SMRI Bushido Capital US Equity ETF | 0.95% | 1.32% | 0.98% | 0.45% |
Frequently Asked Questions
SMRI and PRXV have a correlation of 0.20, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, PRXV is cheaper at 0.36% per year. The better choice depends on whether you care most about return, fees, risk, or income.
PRXV is cheaper with a 0.36% expense ratio, compared with 0.71% for SMRI.
SMRI has the higher dividend yield at 0.95%, compared with 0.00% for PRXV.
They also come from different issuers: Bushido and Praxis. Their fees differ too: 0.71% for SMRI and 0.36% for PRXV.
Find the right allocation for SMRI and PRXV
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer